Skip to Main Content

Explore Articles

Ideas, trends, and inspiration for a brighter future
Definium Therapeutics Announces Positive Topline Results from Phase 3 Emerge Study of DT120 Orally Disintegrating Tablet (ODT) in Major Depressive Disorder
Jun 22, 2026

Definium Therapeutics Announces Positive Topline Results from Phase 3 Emerge Study of DT120 Orally Disintegrating Tablet (ODT) in Major Depressive Disorder

READ MORE
Happy International Clinical Trials Day!
May 20, 2026

Happy International Clinical Trials Day!

READ MORE
Cheers to a Successful Year for Compass Pathways
Mar 24, 2026

Cheers to a Successful Year for Compass Pathways

READ MORE
Compass Pathways Successfully Achieves Primary Endpoint in Second Phase 3 Trial Evaluating COMP360 Psilocybin for Treatment-Resistant Depression
Feb 17, 2026

Compass Pathways Successfully Achieves Primary Endpoint in Second Phase 3 Trial Evaluating COMP360 Psilocybin for Treatment-Resistant Depression

READ MORE
Therapy Dogs Ease Loneliness Among People Hospitalized For Mental Illness
Feb 9, 2026

Therapy Dogs Ease Loneliness Among People Hospitalized For Mental Illness

READ MORE
Xanomeline and Trospium Chloride Proven Successful Treatment For Schizophrenia
Feb 5, 2026

Xanomeline and Trospium Chloride Proven Successful Treatment For Schizophrenia

READ MORE
Seasonal Affective Disorder: Symptoms and Treatment
Dec 5, 2025

Seasonal Affective Disorder: Symptoms and Treatment

READ MORE
Celebrating Dr. Parikh’s Achievement
Dec 5, 2025

Celebrating Dr. Parikh’s Achievement

READ MORE
U.S. Vaccine Policy Faces Major Scrutiny: What You Need to Know
Dec 3, 2025

U.S. Vaccine Policy Faces Major Scrutiny: What You Need to Know

READ MORE